We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Tactile Systems Technology
TCMD
$620M
| $261K | ﹤0.01% |
3,860
| – | – |
|
1702
Mercantile Bank Corp
MBWM
$1.01B
| $260K | ﹤0.01% |
7,144
+895
| +14% | +$31.5K |
|
|
ZNGA
1703
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $260K | ﹤0.01% |
42,484
-287
| -0.7% | -$1.77K |
|
1704
Triumph Financial Inc
TFIN
$1.84B
| $259K | ﹤0.01% |
6,815
+2,664
| +64% | +$92K |
|
1705
Columbia Sportswear
COLM
$3.19B
| $257K | ﹤0.01% |
2,559
-250
| -9% | -$23.7K |
|
1706
First Trust Global Wind Energy ETF
FAN
$281M
| $257K | ﹤0.01% |
17,555
| – | – |
|
1707
Kennametal
KMT
$2.68B
| $257K | ﹤0.01% |
6,972
+4,992
| +252% | +$167K |
|
1708
Quanta Services
PWR
$93.9B
| $257K | ﹤0.01% |
6,326
-500
| -7% | -$20.4K |
|
|
CLVS
1709
DELISTED
Clovis Oncology, Inc.
CLVS
| $256K | ﹤0.01% |
24,500
+19,500
| +390% | +$142K |
|
1710
Invesco Zacks Mid-Cap ETF
CZA
$188M
| $255K | ﹤0.01% |
3,308
+500
| +18% | +$37.3K |
|
1711
FormFactor
FORM
$8.11B
| $255K | ﹤0.01% |
9,833
| – | – |
|
1712
Goodyear
GT
$2.07B
| $255K | ﹤0.01% |
16,407
-3,139
| -16% | -$49.1K |
|
|
WBC
1713
DELISTED
WABCO HOLDINGS INC.
WBC
| $255K | ﹤0.01% |
1,874
+99
| +6% | +$13.3K |
|
1714
Woori Financial
WF
$15.8B
| $254K | ﹤0.01% |
8,407
+3,476
| +70% | +$106K |
|
1715
BJs Wholesale Club
BJ
$11.9B
| $253K | ﹤0.01% |
11,127
+2,866
| +35% | +$70.8K |
|
1716
iShares Expanded Tech Sector ETF
IGM
$9.94B
| $253K | ﹤0.01% |
6,288
-600
| -9% | -$22.9K |
|
|
EQC
1717
DELISTED
Equity Commonwealth
EQC
| $253K | ﹤0.01% |
7,706
-534
| -6% | -$17.2K |
|
|
LPT
1718
DELISTED
Liberty Property Trust
LPT
| $253K | ﹤0.01% |
4,215
+17
| +0.4% | +$974 |
|
|
BLUE
1719
DELISTED
bluebird bio
BLUE
| $252K | ﹤0.01% |
221
-94
| -30% | -$102K |
|
1720
eHealth
EHTH
$42.5M
| $252K | ﹤0.01% |
2,622
+1,685
| +180% | +$131K |
|
1721
Inogen
INGN
$167M
| $252K | ﹤0.01% |
3,676
-44
| -1% | -$2.76K |
|
|
XIFR
1722
XPLR Infrastructure LP
XIFR
$1.18B
| $252K | ﹤0.01% |
4,779
+715
| +18% | +$37.2K |
|
|
SP
1723
DELISTED
SP Plus Corporation
SP
| $251K | ﹤0.01% |
5,904
+2,758
| +88% | +$116K |
|
1724
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$781B
| $250K | ﹤0.01% |
+48
| New | +$14.8K |
|
|
LM
1725
DELISTED
Legg Mason, Inc.
LM
| $249K | ﹤0.01% |
6,924
+124
| +2% | +$4.6K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.